Wart Remover

Description

The product is identified by the SPL Code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the removal of genital warts, plantar warts, common warts, and flat warts. Common warts are characterized by their rough, "cauliflower-like" surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the application process. After soaking, the area must be dried completely.

Using an applicator, such as a cotton swab, a layer of ointment should be applied to sufficiently cover each wart. It is important to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in patients experiencing persistent discomfort, as well as in individuals with diabetes or poor blood circulation due to potential exacerbation of these conditions.

Contact with the eyes should be strictly avoided; in the event of exposure, the eyes must be flushed with water for 15 minutes. Additionally, inhalation of vapors is contraindicated to prevent respiratory irritation.

Warnings and Precautions

For external use only. It is imperative to keep the product away from fire and flame to prevent any potential hazards.

In the event of accidental ingestion, immediate medical assistance is required. Healthcare professionals should advise patients to contact a Poison Control Center at 1-800-222-1222 or seek emergency medical help without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if discomfort persists. Special caution is advised for individuals with diabetes or poor blood circulation, as these conditions may exacerbate potential adverse effects. Regular monitoring of these patients is recommended to ensure their safety while using the product.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event of discomfort persisting after application, patients are advised to discontinue use. This recommendation is particularly important for individuals with diabetes or those who have poor blood circulation, as these conditions may increase the risk of adverse reactions.

Drug Interactions

No drug interactions have been identified for the product, indicating that it does not have clinically significant interactions with other medications. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product for external application only. Care must be taken to avoid contact with the eyes; in the event of exposure, the eye should be flushed with water for 15 minutes. If discomfort persists, or if the patient has diabetes or poor blood circulation, consultation with a healthcare professional is advised.

In cases of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted. Prior to application, the affected area should be washed, and warts may be soaked in warm water for 5 minutes, followed by thorough drying.

Using a cotton swab applicator, a layer of ointment should be applied to sufficiently cover each wart. The area should be allowed to fully absorb the medication, and a bandage may be applied as needed. This procedure may be repeated once or twice daily as necessary, up to a maximum duration of 12 weeks, until the wart is removed.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, which may include a risk of fetal harm if used during this period. Therefore, pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for healthcare professionals to counsel women of childbearing potential regarding these risks and to consider alternative treatments when necessary.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is important to inform patients that if they experience persistent discomfort, they should discontinue use and consult a doctor, particularly if they have diabetes or poor blood circulation.

Patients should be cautioned to avoid contact with their eyes. In the event that the product comes into contact with the eyes, they should flush the area with water for at least 15 minutes. Additionally, healthcare providers should emphasize the importance of avoiding inhalation of vapors associated with the product.

Providers should instruct patients to ensure that the tube is capped tightly after use to maintain product integrity. Furthermore, patients should be informed about proper storage conditions, which include keeping the product out of direct sunlight and at room temperature, away from heat sources.

Storage and Handling

The product is supplied in packaging that ensures its integrity during storage and handling. It should be stored out of direct sunlight and maintained at room temperature, away from heat sources. Proper storage conditions are essential to preserve the product's efficacy and safety.

Additional Clinical Information

The product is administered topically, with a recommended frequency of once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should advise patients that the product is for external use only and to keep it away from fire and flame. Patients should be cautioned to avoid contact with the eyes; in case of exposure, they should flush the eye with water for 15 minutes. Inhalation of vapors should be avoided, and the tube should be capped tightly and stored at room temperature, away from direct sunlight and heat.

Patients experiencing persistent discomfort, those with diabetes, or individuals with poor blood circulation should seek medical advice. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center (1-800-222-1222) is recommended.

Drug Information (PDF)

This file contains official product information for Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)